This study will enroll HIV-infected people who do not have evidence of active TB but who are at high risk of developing active...
The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
Purpose: The C-TRIUMPH study has identified 20 household contacts (HHC), who have progressed to active TB from its HHCs cohort...
